Senvest Management, LLC Evogene Ltd. Transaction History

Senvest Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.45 - $3.45 $550,598 - $775,332	-224,734 Reduced 49.36%	230,606 $609,000
Q2 2021 Aug 13, 2021	SELL	$3.3 - $5.02 $946,067 - $1.44 Million	-286,687 Reduced 38.64%	455,340 $1.56 Million
Q1 2021 May 14, 2021	BUY	$4.29 - $9.94 $1.15 Million - $2.67 Million	268,370 Added 56.66%	742,027 $3.74 Million
Q4 2020 Feb 12, 2021	SELL	$2.41 - $5.63 $344,531 - $804,859	-142,959 Reduced 23.18%	473,657 $2.23 Million
Q3 2020 Nov 13, 2020	BUY	$0.97 - $4.08 $137,675 - $579,090	141,934 Added 29.9%	616,616 $2.44 Million
Q2 2020 Aug 13, 2020	BUY	$0.92 - $1.29 $55,200 - $77,400	60,000 Added 14.47%	474,682 $475,000
Q2 2019 Aug 13, 2019	BUY	$1.4 - $2.47 $387,720 - $684,049	276,943 Added 201.06%	414,682 $668,000
Q3 2017 Nov 13, 2017	BUY	$4.24 - $5.06 $584,013 - $696,959	137,739	137,739 $612,000

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $61M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Senvest Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Senvest Management, LLC with notifications on news.